HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Applications and modifications of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) in peptides and peptidomimetics design and discovery.

Abstract
Tic, short for 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, is a kind of unnatural α-amino acids. Due to its distinct geometrical conformation and biological activity, the structure of Tic, regarded as the surrogate of proline and the rigid analogue of phenylalanine or tyrosine, has been introduced into many compounds, which target diverse enzymes or receptors. The most successful example is that substituting the Tic residue for the proline residue of enalapril led to an approved drug quinapril. In this review, we will summarize the applications and modifications of Tic in peptides and peptidomimetics design and discovery, and hope to spark medicinal researchers' inspiration in the field of protein and peptide drug design and optimization.
AuthorsYingjie Zhang, Hao Fang, Wenfang Xu
JournalCurrent protein & peptide science (Curr Protein Pept Sci) Vol. 11 Issue 8 Pg. 752-8 (Dec 2010) ISSN: 1875-5550 [Electronic] United Arab Emirates
PMID21235510 (Publication Type: Journal Article, Review)
Chemical References
  • Peptides
  • Peptidomimetics
  • Tetrahydroisoquinolines
  • 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
  • Tyrosine
  • Phenylalanine
  • Proline
Topics
  • Drug Design
  • Peptides (chemistry)
  • Peptidomimetics
  • Phenylalanine (analogs & derivatives)
  • Proline (chemistry)
  • Tetrahydroisoquinolines (chemistry)
  • Tyrosine (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: